US$ 28.69
tirzepatide weight loss medication FDA Grants a New Indication for Obesity Management How to Take Tirzepatide for
Description
Such guidance (PDF provider updates) shows how PBMs communicate changes to clinicians, forcing them to re-engage affected patients

They do have favorable cardiometabolic effects however (weight loss, amongst others)

Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults
What I found especially noteworthy is that the reduction appeared stronger for venous thromboembolic events than for some arterial cardiovascular outcomes such as myocardial infarction

doi: 10.4093/dmj.2019.0018

Fortinos blog: Tirzepatide vs
